None

Fiber Metabolism in Chronic Obstructive Pulmonary Disease

This protocol is an extension of a recent study about whole-body SCFA production rates in COPD patients. The investigators hypothesize that a short-term fiber supplementation increases SCFA production in COPD patients.

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease

To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with COPD

COPD-ICU Multicentre Prospective Observational Register (COPD-ICU)

This is a randomized, open-label, parallel group study to determine the optimal dose of CART-19 cells (of the two dose levels being assessed (1-5x10xE8 vs. 1-5x10xE7 CART-19 cells). This trial will be conducted in two stages. In Stage 2, the selected dose cohort will be expanded to enroll additional subjects, …

scrumsecond sync

This is a randomized, open-label, parallel group study to determine the optimal dose of CART-19 cells (of the two dose levels being assessed (1-5x10xE8 vs. 1-5x10xE7 CART-19 cells). This trial will be conducted in two stages. In Stage 2, the selected dose cohort will be expanded to enroll additional subjects, …

PQ Test Trial ( Do not edit)  

George's Respiratory Questionnaire (SGRQ) in former smokers with moderate-to-severe COPDEvaluate the safety and tolerability of itepekimab in former smokers with moderate-to-severe COPDEvaluate the pharmacokinetic (PK) profile of itepekimab in former smokers with moderate-to-severe COPDEvaluate immunogenicity to itepekimab in former smokers with moderate-to-severe COPDSecondary population (current smokers cohort)Estimate the efficacy of …

To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI

Paniculata and A.Chilensis are effective and safe in the treatment of typical cold-related symptoms in adults.

Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection

SNG001 is an inhaled formulation of interferon beta-1a it is currently in Phase II clinical trials for COPD patients. Synairgen has conducted randomised placebo controlled clinical trials of SNG001 involving >200 asthma and COPD patients.

Understanding Factors That Influence Electronic Cigarette Nicotine Delivery Through PET Imaging of Beta-2 Nicotinic Acetylcholine Receptors

The goal of this proposal is to test the overall hypothesis that e-cigarettes (ECs) provide efficient nicotine delivery to the brain and arterial blood in non-EC-nave smokers and e-cigarette users and that EC liquid characteristics modulate this effect. This study will test the hypothesis through complementary methods that include [ …

A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus  

This is an intervention, phase IV, single-arm study to assess the safety and efficacy of iGlarLixi in adult patients with Type 2 diabetes.